HA-Cdk9 Citations (3)

Originally described in: Phosphatase PPM1A regulates phosphorylation of Thr-186 in the Cdk9 T-loop.
Wang Y, Dow EC, Liang YY, Ramakrishnan R, Liu H, Sung TL, Lin X, Rice AP J Biol Chem. 2008 Nov 28. 283(48):33578-84. PubMed Journal

---

Articles Citing HA-Cdk9

Articles
Ovarian cancer-associated mutations disable catalytic activity of CDK12, a kinase that promotes homologous recombination repair and resistance to cisplatin and poly(ADP-ribose) polymerase inhibitors. Joshi PM, Sutor SL, Huntoon CJ, Karnitz LM. J Biol Chem. 2014 Mar 28;289(13):9247-53. doi: 10.1074/jbc.M114.551143. Epub 2014 Feb 19. PubMed
The CDK4/6-EZH2 pathway is a potential therapeutic target for psoriasis. Muller A, Dickmanns A, Resch C, Schakel K, Hailfinger S, Dobbelstein M, Schulze-Osthoff K, Kramer D. J Clin Invest. 2020 Jul 23. pii: 134217. doi: 10.1172/JCI134217. PubMed
Discovery of a tetrahydroisoquinoline-based CDK9-cyclin T1 protein-protein interaction inhibitor as an anti-proliferative and anti-migration agent against triple-negative breast cancer cells. Cheng S, Yang GJ, Wang W, Ma DL, Leung CH. Genes Dis. 2021 Jul 10;9(6):1674-1688. doi: 10.1016/j.gendis.2021.06.005. eCollection 2022 Nov. PubMed

If you have published an article using this material, please email us at to have your article added to this page.